Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Robinson

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Pigment Cell & Melanoma Research|May 9, 2009
Met amplification and tumor progression in Cdkn2a-deficient melanocytesMatthew W Vanbrocklin, James P Robinson, Todd Whitwam, et al.
Cell Reports|November 14, 2015
AKT1 Activation Promotes Development of Melanoma MetastasesJoseph H Cho, James P Robinson, Rowan A Arave, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
Evidence for an association between compound heterozygosity for germ line mutations in the hemochromatosis (HFE) gene and increased risk of colorectal cancerJames P Robinson, Victoria L Johnson, Pauline A Rogers, et al.
Current Biology : CB|December 27, 2024
The histone H3.3 K27M mutation suppresses Ser31phosphorylation and mitotic fidelity, which can directly drive gliomagenesisCharles A Day, Florina Grigore, Faruck L Hakkim, et al.
Melanoma Research|October 28, 2017
Resistance mechanisms to genetic suppression of mutant NRAS in melanomaJames P Robinson, Vito W Rebecca, David A Kircher, et al.
Cell Reports|May 3, 2018
Mutant IDH1 Promotes Glioma Formation In VivoBeatrice Philip, Diana X Yu, Mark R Silvis, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2008
Unregulated smooth-muscle myosin in human intestinal neoplasiaPia Alhopuro, Denis Phichith, Sari Tuupanen, et al.
Pain|December 9, 2003
Core outcome domains for chronic pain clinical trials: IMMPACT recommendationsDennis C Turk, Robert H Dworkin, Robert R Allen, et al.
Pain|April 19, 2015
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain Reports|May 13, 2021
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Pigment Cell & Melanoma Research|May 9, 2009
Met amplification and tumor progression in Cdkn2a-deficient melanocytesMatthew W Vanbrocklin, James P Robinson, Todd Whitwam, et al.
Cell Reports|November 14, 2015
AKT1 Activation Promotes Development of Melanoma MetastasesJoseph H Cho, James P Robinson, Rowan A Arave, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
Evidence for an association between compound heterozygosity for germ line mutations in the hemochromatosis (HFE) gene and increased risk of colorectal cancerJames P Robinson, Victoria L Johnson, Pauline A Rogers, et al.
Current Biology : CB|December 27, 2024
The histone H3.3 K27M mutation suppresses Ser31phosphorylation and mitotic fidelity, which can directly drive gliomagenesisCharles A Day, Florina Grigore, Faruck L Hakkim, et al.
Melanoma Research|October 28, 2017
Resistance mechanisms to genetic suppression of mutant NRAS in melanomaJames P Robinson, Vito W Rebecca, David A Kircher, et al.
Cell Reports|May 3, 2018
Mutant IDH1 Promotes Glioma Formation In VivoBeatrice Philip, Diana X Yu, Mark R Silvis, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2008
Unregulated smooth-muscle myosin in human intestinal neoplasiaPia Alhopuro, Denis Phichith, Sari Tuupanen, et al.
Pain|December 9, 2003
Core outcome domains for chronic pain clinical trials: IMMPACT recommendationsDennis C Turk, Robert H Dworkin, Robert R Allen, et al.
Pain|April 19, 2015
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pain Reports|May 13, 2021
Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendationsJennifer S Gewandter, Robert H Dworkin, Dennis C Turk, et al.
Pageof 5